Compare XNCR & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | DHC |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2013 | 1998 |
| Metric | XNCR | DHC |
|---|---|---|
| Price | $33.57 | $7.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $43.83 | $9.88 |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | ★ 65.36 | 23.23 |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $1,074,819,000.00 |
| Revenue This Year | $58.19 | N/A |
| Revenue Next Year | N/A | $5.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.65 | 1.59 |
| 52 Week Low | $10.38 | $4.51 |
| 52 Week High | $40.60 | $9.66 |
| Indicator | XNCR | DHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 36.54 |
| Support Level | $22.80 | $6.92 |
| Resistance Level | $33.60 | $7.59 |
| Average True Range (ATR) | 2.08 | 0.33 |
| MACD | -0.54 | -0.02 |
| Stochastic Oscillator | 35.21 | 30.28 |
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.